C12N 2710/14161
Methods of inactivation or attenuation
C12N2710/14161 (Methods of inactivation or attenuation) appears on 10 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 10
- Published applications
- 16
- Assignees
- 6
- Inventors
- 12
- Latest grant
- 3 Mar 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 6 |
| 2010 | 2 | 0 |
| 2011 | 2 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 3 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- PCV2 immunogenic compositions and methods of producing such compositions3 Mar 2020US 10,576,142 B2
- Anti-viral azide containing compounds15 Jan 2019US 10,179,143 B2Life Technologies Corporation
- PCV2 immunogenic compositions and methods of producing such compositions20 Mar 2018US 9,919,041 B2Boehringer Ingelheim Vetmedica GmbH
- PCV2 immunogenic compositions and methods of producing such compositions21 Apr 2015US 9,011,872 B2Boehringer Ingelheim Vetmedica GmbH
- Baculoviruses with enhanced virion production and a method for the production of baculoviruses22 Apr 2014US 8,703,469 B2Boyce Thompson Institute for Plant Research, Inc.
- Anti-Viral Azide Containing Compounds11 Apr 2019US 2019/0105334 A1Life Technologies Corporation
- Pcv2 immunogenic compositions and methods of producing such compositions21 Jun 2018US 2018/0169214 A1Boehringer Ingelheim Vetmedica GmbH
- Anti-Viral Azide Containing Compounds23 Nov 2017US 2017/0333457 A1Life Technologies Corporation
- Pcv2 immunogenic compositions and methods of producing such compositions9 Jul 2015US 2015/0190497 A1Boehringer Ingelheim Vetmedica GmbH
- Anti-Viral Azide Containing Compounds15 Aug 2013US 2013/0209364 A1Life Technologies Corporation
Most cited
By later US patents
- PCV2 immunogenic compositions and methods of producing such compositions36US 7,829,101 B2Boehringer Ingelheim Vetmedica GmbH · 2010
- PCV2 immunogenic compositions and methods of producing such compositions31US 7,910,306 B2Boehringer Ingelheim Vetmedica GmbH · 2011
- PCV2 immunogenic compositions and methods of producing such compositions29US 8,025,888 B2Boehringer Ingelheim Vetmedica GmbH · 2011
- Methods of overexpression and recovery of porcine circovirus type 2 ORF227US 7,833,707 B2Boehringer Ingelheim Vetmedica GmbH · 2010
- PCV2 immunogenic compositions and methods of producing such compositions21US 9,011,872 B2Boehringer Ingelheim Vetmedica GmbH · 2015